Description |
transforming growth factor beta receptor 2 |
zinc finger FYVE-type containing 9 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Breast cancer ( 29059683 23535729)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Estimated glomerular filtration rate ( 31152163)
- Heel bone mineral density ( 30598549)
- Metabolite levels ( 23823483)
- Migraine ( 22683712 27322543)
- Migraine - clinic-based ( 23793025)
- Night sleep phenotypes ( 27126917)
- Postprandial triglyceride response ( 32603185)
- Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) ( 25117820)
- Systolic blood pressure ( 30224653)
- Tonometry ( 17903302)
|
- Hip circumference adjusted for BMI ( 34021172)
|
Interacting Genes |
50 interacting genes:
ACVR1
ACVRL1
AP2B1
APP
ARHGEF6
ARHGEF7
CCNB1
CCNB2
CD44
CDK1
CLU
CTNNB1
DAB2
DAXX
DYNLT4
EIF3I
ENG
FANCC
GOPC
KCNK18
MAP2K1
NRP1
OSR1
PAK1
PDGFRA
PIK3R1
PIK3R2
PML
PPP2CB
PSMD14
RCVRN
SMAD3
SMAD4
SMAD7
SNX6
STRAP
TDGF1
TERT
TGFB1
TGFB1I1
TGFB2
TGFB3
TGFBR1
TGFBR3
TGFBRAP1
TRAP1
TRMO
TSSK1B
ZFYVE9
ZNF510
|
40 interacting genes:
ANKLE2
ATP6V0B
BAG6
BMP4
CHD6
CLTC
CTNNB1
DAZAP2
EIF4G1
ERBIN
ETS2
FHL2
JUP
LRP12
NIT1
NRDC
NUP155
PML
PPP1CA
PPP1CB
PPP1CC
PPP2R1A
RBBP6
RHOT2
RNF11
RNPEP
SCYL2
SMAD2
SMAD3
SPART
ST7
SUMF2
SUPT5H
SVEP1
TENT5A
TGFBR1
TGFBR2
UBC
UBXN11
ZMYND8
|
Entrez ID |
7048 |
9372 |
HPRD ID |
01823 |
04782 |
Ensembl ID |
ENSG00000163513
|
ENSG00000157077
|
Uniprot IDs |
A3QNQ0
D2JYI1
P37173
|
O95405
|
PDB IDs |
1KTZ
1M9Z
1PLO
2PJY
3KFD
4P7U
4XJJ
5E8V
5E8Y
5E91
5E92
5QIN
5TX4
5TY4
|
1DEV
1MK2
4BKW
5MJY
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|